To further test the hypothesis in vivo, we deleted NPRC [9] specifically in glomerular podocytes in a transgenic (TG) mouse model of FSGS created in our laboratory [23], This model sensitizes mice to the podocyte toxin puromycin aminonucleoside (PAN). The gene discussed is NPR3; the disease is focal segmental glomerulosclerosis.